Cartesian Therapeutics Inc. (RNAC NASDAQ) stock market data APIs
$9.6117
0.48(5%)
as of August 28, 2026
Try our APIs with
free plan!
Cartesian Therapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Prev. Close
9.6117
Open
10.092
High
10.5848
Low
9.516
52 wk Range
5.6-11
Market Cap
290 M
Shares Outstanding
30 255 K
Revenue
1 477 K
EPS
0.46
Beta
0.565
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cartesian Therapeutics Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cartesian Therapeutics Inc. data using free add-ons & libraries
Get Cartesian Therapeutics Inc. Fundamental Data
Cartesian Therapeutics Inc. Fundamental data includes:
- Net Revenue: 1 477 K
- EBITDA: -96 051 000
- Earnings Per Share: -5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Cartesian Therapeutics Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.83
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cartesian Therapeutics Inc. News
New
Cartesian Therapeutics Announces New Employment Inducement Grants
FREDERICK, Md., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune ...
Kyverna Therapeutics Sinks 13%: Here’s Why
Quick Read KYTX dropped 12% after JPMorgan trimmed its price target to $29, despite beating Q1 estimates and initiating a rolling BLA for miv-cel targeting a 2027 launch. BEAM slid 8% from a 52-week ...
New Strong Sell Stocks for July 1st
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Caesars Entertainment, Inc. CZR is a gaming and hospitality company. The Zacks Consensus Estimate for its current year earni...
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?
Kiniksa Pharmaceuticals International, plc (KNSA) shares soared 5.4% in the last trading session to close at $62.41. The move was backed by solid volume with far more shares changing hands than in a n...
Get Cartesian Therapeutics Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
